Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
Many papers have previously suggested an association between the long-term use of statins (e.g., simvastatin/Zocor and atorvastatin/Lipitor) or nonsteroidal anti-inflammatory drugs (NSAIDs, like aspirin), the risk of prostate cancer diagnosis, and the overall survival of men diagnosed with prostate cancer.
Filed under: Living with Prostate Cancer, Management, Prevention, Treatment | Tagged: mortality, NSAID, overall, statin | Leave a Comment »
Because it takes so long for men with even advanced prostate cancer to progress through to death from any cause, there has been extensive effort over the years to define “surrogate” endpoints for prostate cancer-specific and overall survival in prostate cancer clinical trials.
Filed under: Drugs in development | Tagged: enpoint, overall, PSA progression, surrogate, survival | Leave a Comment »
Two studies presented at the AUA on Monday dealt with the mortality rates of men diagnosed with prostate cancer and treated with differing types of first line therapy.
Filed under: Management, Treatment, Uncategorized | Tagged: mortality, overall, prostate cancer-specific | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site